Trupanion (NASDAQ:TRUP) Downgraded by Zacks Research to “Hold”

Zacks Research downgraded shares of Trupanion (NASDAQ:TRUP) from a strong-buy rating to a hold rating in a research note published on Monday,Zacks.com reports.

TRUP has been the topic of a number of other reports. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and set a $32.00 price objective on the stock. in a report on Wednesday. Weiss Ratings upgraded Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, August 12th. Stifel Nicolaus lifted their price target on Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research report on Thursday, August 20th. Finally, Atlantic Securities set a $42.00 price target on Trupanion in a research note on Wednesday, July 15th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $39.20.

Trupanion Stock Up 0.3%

NASDAQ:TRUP opened at $31.84 on Monday. The company has a market cap of $1.40 billion, a PE ratio of 60.08, a P/E/G ratio of 2.15 and a beta of 1.39. Trupanion has a twelve month low of $21.16 and a twelve month high of $46.98. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. The company’s 50 day moving average is $26.63 and its two-hundred day moving average is $26.02.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. The business had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. Trupanion’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.22 EPS. Analysts anticipate that Trupanion will post 0.63 EPS for the current year.

Insider Activity at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 978 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total value of $28,410.90. Following the completion of the transaction, the chief executive officer directly owned 175,401 shares of the company’s stock, valued at approximately $5,095,399.05. The trade was a 0.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO John R. Gallagher sold 3,603 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $21.69, for a total transaction of $78,149.07. Following the sale, the chief operating officer directly owned 33,065 shares in the company, valued at $717,179.85. The trade was a 9.83% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 12,117 shares of company stock worth $275,123. 5.58% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Trupanion

A number of large investors have recently bought and sold shares of TRUP. Thrivent Financial for Lutherans grew its holdings in shares of Trupanion by 1.1% in the 2nd quarter. Thrivent Financial for Lutherans now owns 24,853 shares of the financial services provider’s stock worth $1,376,000 after acquiring an additional 282 shares during the period. EP Wealth Advisors LLC increased its position in shares of Trupanion by 2.9% in the second quarter. EP Wealth Advisors LLC now owns 10,310 shares of the financial services provider’s stock valued at $571,000 after buying an additional 292 shares in the last quarter. Illinois Municipal Retirement Fund increased its position in shares of Trupanion by 2.3% in the first quarter. Illinois Municipal Retirement Fund now owns 17,819 shares of the financial services provider’s stock valued at $456,000 after buying an additional 406 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Trupanion by 2.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 33,657 shares of the financial services provider’s stock worth $1,258,000 after buying an additional 725 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Trupanion by 3.8% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,340 shares of the financial services provider’s stock worth $1,126,000 after buying an additional 737 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.